Diverse role of survival motor neuron protein

RN Singh, MD Howell, EW Ottesen… - Biochimica et Biophysica …, 2017 - Elsevier
Abstract The multifunctional Survival Motor Neuron (SMN) protein is required for the survival
of all organisms of the animal kingdom. SMN impacts various aspects of RNA metabolism …

Emerging therapies and challenges in spinal muscular atrophy

MA Farrar, SB Park, S Vucic, KA Carey… - Annals of …, 2017 - Wiley Online Library
Spinal muscular atrophy (SMA) is a hereditary neurodegenerative disease with severity
ranging from progressive infantile paralysis and premature death (type I) to limited motor …

Stress induces dynamic, cytotoxicity-antagonizing TDP-43 nuclear bodies via paraspeckle LncRNA NEAT1-mediated liquid-liquid phase separation

C Wang, Y Duan, G Duan, Q Wang, K Zhang, X Deng… - Molecular cell, 2020 - cell.com
Despite the prominent role of TDP-43 in neurodegeneration, its physiological and
pathological functions are not fully understood. Here, we report an unexpected role of TDP …

Oxidative stress: roles in skeletal muscle atrophy

H Zhang, G Qi, K Wang, J Yang, Y Shen, X Yang… - Biochemical …, 2023 - Elsevier
Oxidative stress, inflammation, mitochondrial dysfunction, reduced protein synthesis, and
increased proteolysis are all critical factors in the process of muscle atrophy. In particular …

The role of survival motor neuron protein (SMN) in protein homeostasis

H Chaytow, YT Huang, TH Gillingwater… - Cellular and Molecular …, 2018 - Springer
Ever since loss of survival motor neuron (SMN) protein was identified as the direct cause of
the childhood inherited neurodegenerative disorder spinal muscular atrophy, significant …

The first orally deliverable small molecule for the treatment of spinal muscular atrophy

RN Singh, EW Ottesen, NN Singh - Neuroscience Insights, 2020 - journals.sagepub.com
Spinal muscular atrophy (SMA) is one of the leading causes of infant mortality. SMA is
mostly caused by low levels of Survival Motor Neuron (SMN) protein due to deletion of or …

How the discovery of ISS-N1 led to the first medical therapy for spinal muscular atrophy

NN Singh, MD Howell, EJ Androphy, RN Singh - Gene therapy, 2017 - nature.com
Spinal muscular atrophy (SMA), a prominent genetic disease of infant mortality, is caused by
low levels of survival motor neuron (SMN) protein owing to deletions or mutations of the …

Diverse targets of SMN2-directed splicing-modulating small molecule therapeutics for spinal muscular atrophy

EW Ottesen, NN Singh, D Luo, B Kaas… - Nucleic Acids …, 2023 - academic.oup.com
Designing an RNA-interacting molecule that displays high therapeutic efficacy while
retaining specificity within a broad concentration range remains a challenging task …

ISS-N1 makes the first FDA-approved drug for spinal muscular atrophy

EW Ottesen - Translational neuroscience, 2017 - degruyter.com
Spinal muscular atrophy (SMA) is one of the leading genetic diseases of children and
infants. SMA is caused by deletions or mutations of Survival Motor Neuron 1 (SMN1) gene …

Mechanism of splicing regulation of spinal muscular atrophy genes

RN Singh, NN Singh - RNA Metabolism in Neurodegenerative Diseases, 2018 - Springer
Spinal muscular atrophy (SMA) is one of the major genetic disorders associated with infant
mortality. More than 90% cases of SMA result from deletions or mutations of Survival Motor …